Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03713268 · ClinicalTrials.gov registry record

Intraoperative OCT Guidance of Intraocular Surgery II

A clinical trial of Healthy and Cataract, sponsored by Duke University.

Recruiting
Registry status
262
Enrollment target
1
Study location

NCT03713268 is a study of Healthy and Cataract that is actively recruiting participants, run by Duke University. The registered enrollment target is 262 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03713268, a study of Healthy and Cataract, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
262 participants
Enrollment target
1
Study location

Study Summary

The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery, improving surgical practice and outcomes. The investigators believe this technology will enable novel ophthalmic and other microsurgeries not possible due to current limitations in surgical visualization.

Interventions

  • DEVICE Microscope integrated optical coherence tomography

Study Locations (1)

North Carolina

  • Duke University Eye Center - Durham

Trial Details

FieldValue
Enrollment Target 262 participants
Start Date 2018-09-30
Est. Completion 2027-05-31

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT03713268

The ClinicalTrials.gov registry entry for NCT03713268 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 262 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (60% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Microscope integrated optical coherence tomography is the first listed.

NCT03713268 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03713268 about?

NCT03713268 is a clinical study titled "Intraoperative OCT Guidance of Intraocular Surgery II". The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery, improving surgical practice and outcomes. The investigators believe this technology will enable novel ophthalmic and other mic...

What is the current status of trial NCT03713268?

This trial is currently recruiting. The enrollment target is 262 participants. The study started on 2018-09-30. Estimated completion is 2027-05-31.

What conditions does trial NCT03713268 study?

This clinical trial studies the following conditions: Healthy, Cataract, Diabetic Retinopathy, Retinal Disease, Strabismus.

What interventions are being tested in trial NCT03713268?

The interventions under investigation include: Microscope integrated optical coherence tomography (DEVICE).

Who is sponsoring clinical trial NCT03713268?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03713268 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.